Near the end of the BUD, any additional unrefrigerated time carries proportionally more risk
Recommended starting dose: Discontinue other basal insulin and/or GLP-1 agonist before initiating Xultophy Patients nave to basal insulin or a GLP-1 agonist: starting dose is 10 units once daily Patients currently on basal insulin or a GLP-1 agonist: starting dose is 16 units once daily Maintenance: titrate dose up or down by 2 units once or twice weekly, depending on blood sugar goals Missed doses: resume dosing at the next scheduled dose
Barth syndrome Barth syndrome, an X-linked mitochondrial disorder, is characterized by a clinical triad of cardiomyopathy, skeletal myopathy, and neutropenia, along with aberrant cristae morphology and respiratory chain abnormalities
Descriptive statistics were utilized to summarize demographic information and clinical factor data
This drug acts by inhibiting the action of integrin, which is a protein involved in neutrophil function and migration by interacting with cellular adhesion molecules to allow for leukocyte adhesion to that vessel wall